In [**Month (only) 216**] of [**2135**], she was started on dexamethasone after she presented with progressive weakness of her lower extremities and was found to have thoraco-lumbar metastasis to her spinal cord.
She started external beam therapy to the spine in [**Month (only) 216**] in addition to steroids but remained nonambulatory.
In mid-[**Month (only) 216**] she developed worsening headaches, nausea, blurry vision and subsquently underwent placement of a ventriculostomy and Ommaya reservoir.
She has been continued on chemotherapy (ipilimumab and venurafenib).
She underwent wide local excision and bilateral inguinal node sentinel lymph node biopsy which revealed no melanoma.
Her torso CT revealed to be stable with further reduction of her disease, however, on head CT two suspicious lesion 1.0 cm in left frontal lobe and in the periventricular white matter on the left note is made of a small hyperdense focus which also enhances on post-contrast imaging, measuring in total 4 mm x 3 mm.
She began ipilimumab off protocol on [**2136-6-19**].
She was placed on dexamethasone 8 mg twice a day and was scheduled to see our radiation oncologist for consultation.
She was discharged on dexamethasone 8 mg three times a day.
With rapid progression of disease off of vemurafenib, it was decided and she agreed to enroll on protocol 11-101 without WBXRT.
She began protocol 11-101 on [**2136-7-18**] on expanded access protocol.
She finished 28 days worth of treatment and will finish 30 days supply as per the protocol and will transition over to commercial drug (Zelboraf) due to FDA approval of the drug.
She used marijuana in college.
Physical Exam: BP 144/99, HR 95, temp 98, RR 12, SpO2 94% Gen: Caucasian female, lying in bed, curled in fetal position, resisting placement of nasal cannulus Neuro: as noted, makes some purposeful movements (resists placement of nasal cannulus) however not otherwise following instructions, nodded head, lethargic, normoreflexic throughout, no cerebral posturing evident;  pupils mid-size, minimally reactive to light Cardiac: Nl s1/s2 RRR Pulm: clear bilaterally Abd: soft NT ND + BS Ext: no edema noted   Pertinent Results: [**2136-10-12**] 11:15PM BLOOD WBC-9.9 RBC-5.06 Hgb-15.1 Hct-45.0 MCV-89 MCH-29.8 MCHC-33.5 RDW-13.2 Plt Ct-430 [**2136-10-12**] 11:15PM BLOOD PT-12.1 PTT-17.6* INR(PT)-1.0 [**2136-10-12**] 11:15PM BLOOD Glucose-153* UreaN-11 Creat-0.7 Na-141 K-4.0 Cl-101 HCO3-25 AnGap-19 [**2136-10-13**] 06:25AM BLOOD Calcium-9.9 Phos-5.1* Mg-2.3  Studies: CT Head: 1.
No associated hydrocephalus, although a right ventriculostomy catheter remains in place.
Started on dexamethasone IV.
Patient's oncologist and neuro-oncologist were consulted and agreed that there were no further options for treatment of the patient's terminal condition.
Medications on Admission: 1. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2  times a day).
2. senna 8.6 mg Tablet Sig: 1-2 Tablets PO BID (2 times a day) as needed for constipation.
3. lorazepam 1 mg Tablet Sig: One (1) Tablet PO twice a day as needed for anxiety or pre-MRI.
4. gabapentin 300 mg Capsule Sig: One (1) Capsule PO Q8H (every 8 hours).
5. dexamethasone 4 mg Tablet Sig: One (1) Tablet PO twice a day for 7 days.
Disp:*30 Tablet(s)* Refills:*0* 6. oxycodone-acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for pain.
Disp:*30 Tablet(s)* Refills:*1* 7. morphine 10 mg/5 mL Solution Sig: [**12-4**] 5 mL PO every eight (8)  hours as needed for pain.
Disp:*10 * Refills:*1* 8. dexamethasone 4 mg Tablet Sig: One (1) Tablet PO once a day: start this regimen after 7 days of taking the medication twice a  day.
Discharge Medications: 1. morphine concentrate 100 mg/5 mL (20 mg/mL) Solution Sig: 5-20 mg PO Q1H as needed for pain/dyspnea: for Hospice.
ZOFRAN ODT 4 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, Rapid Dissolve PO every four (4) hours as needed for nausea.
Dexamethasone 4mg Supp per rectum twice daily   Discharge Disposition: Home With Service  Facility: [**Hospital **] Hospice  Discharge Diagnosis: Metastatic Melanoma Intracranial Hemmorhage   Discharge Condition: Mental Status: Confused - always.
In consultation with her family and our palliative care specialist it was decided to discharge her to home hospice to continue care focused on her comfort.
